# Fibrosis in Renal Allografts

> **NCT00493194** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Antwerp** · enrollment: 100 (estimated)

## Conditions studied

- Kidney Failure, Chronic
- Transplantation
- Immunosuppression
- Interstitial Fibrosis

## Interventions

- **DRUG:** sirolimus
- **DRUG:** cyclosporine
- **DRUG:** daclizumab

## Key facts

- **NCT ID:** NCT00493194
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2008-11-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00493194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00493194, "Fibrosis in Renal Allografts". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00493194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*